Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 +0.00 (+0.02%)
As of: Sep 30, 2026 · 2:26 PM EDT

Pasithea Therapeutics (KTTA) Notes Payables (2023)

Updated

Pasithea Therapeutics (KTTA) recorded Notes Payables of $133,335 in Q2 2023, down 49.5% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Notes Payables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 133,335.00
Mar 31, 2023 264,103.00
API Access

Pasithea Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=KTTA&period=max&api_key=YOUR_API_KEY